Who invested in Incyclix Bio

2 rounds we have observed, with the 3 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 7 months ago

Funding summaryUpdated 26 Oct 2026

$16Mraised across 2 rounds since 2025, from 2 sources

$11MSeries B$5.0MSeries B

Latest round: Series B, $5.0MApr 2026
Biggest round: $11MSeries B · Aug 2025
Investors: 3

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2026

$11MSeries B$5.0MSeries B

First round: Series B, $11M
Biggest round: $11M
Between rounds: 8 months

The rounds

Apr 2026
Series B$5.0M1 new2 returning
Source recorded
Aug 2025
Series B$11M2 new
- RA Capital Management
- Eli Lilly
Source recordedSEC filing: $11M sold, first sale Aug 2025

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Series B2025Series B2026

RA Capital Management

Eli Lilly

Hatteras Venture Partners

Everyone who backed them

RA Capital ManagementPrivate equity2rounds

Eli LillyCorporate VC2rounds

Hatteras Venture PartnersVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Incyclix Bio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.